# Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains

> **NCT07436611** · PHASE2 · NOT_YET_RECRUITING · sponsor: **AFT Pharmaceuticals, Ltd.** · enrollment: 30 (estimated)

## Conditions studied

- Port Wine Stains

## Interventions

- **DRUG:** Rapamycin cream
- **PROCEDURE:** Pulsed dyed laser

## Key facts

- **NCT ID:** NCT07436611
- **Lead sponsor:** AFT Pharmaceuticals, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2027-09
- **Final completion:** 2027-10
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07436611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07436611, "Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07436611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*